Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Featured Practice Guidelines
    • Treatment For Ante...

    Treatment For Ante Partum Haemorrhage: Indian Guidelines

    Written by supriya kashyap kashyap Published On 2016-10-13T12:23:18+05:30  |  Updated On 13 Oct 2016 12:23 PM IST
    Treatment For Ante Partum Haemorrhage: Indian Guidelines

    Ministry of Health and Family Welfare, Government of India has issued the standard Treatment Guidelines for Ante Partum Haemorrhage. Following are the major recommendations :


    Definition:


    APH is defined as bleeding from or into the genital tract occurring from 24th week of pregnancy and prior to the birth of the baby.


    Why it occurs?


    The causes of APH include placenta previa,abruption placenta,local causes and unexplained causes. Local causes comprise vasa previa and cervical or vaginal causes.


    Commonly it is due to:


     Placenta previa


     Abruptio placenta


    It may also be due to:


    - Exaggerated show,


    - Trauma to cervix or vagina


    - Cervical ectropion,


    - Carcinoma of cervix or polyps


    - Vasa previa


    How to diagnose Placenta Previa?


    Definition:


    The term placenta previa refers to a placenta that overlies or is proximate to the internal os of the cervix. The placenta normally implants in the upper uterine segment. In placenta previa, the placenta either totally or partially lies within the lower uterine segment.


    Incidence:


    1 in 300 pregnancies


    Maternal morbidity and mortality is high if it is not treated properly.


    Perinatal morbidity and mortality also are primarily related to the complications of placenta previa, because the hemorrhage is maternal.


    Predisposing factors:


    o Advancing maternal age


    o Multiparty


    Multifetal gestations


    o Prior caesarean delivery


    o Prior placenta previa


    Differential Diagnosis:


    Abruptio placentae, other probable causes.


    Optimal Diagnostic Criteria, investigations, treatment and referral criteria


    Situation 1: At Secondary Hospital/ Non-Metro situation: (Optimal Standards of Treatment in Situations where technology and resources are limited)-

    a) Clinical Diagnosis:


    It is on the basis of history, physical examination and investigations.


     History: Nature of bleeding: Painless, recurrent, bright red. Initial bleeding may not be profuse enough to cause death; but it is a warning sign and requires close monitoring or refer the patient to higher centre.


     On physical examination: Patient might be in shock


    – Abdominal examination: Height of uterus proportionate to gestational age, presenting part may be felt high up (not engaged).


    – Malpresentations, malpositions usually present.


    – Uterine contraction may or may not be present. Some degree of uterine irritability is present in about 20% of the cases.


    – Fetal heart sound may or may not be present, depending upon theamount of blood loss.


    If you suspect placenta previa, do not perform a vaginal examination without preparation. Per vaginal examination should be done in theatre but without any anesthesia with all preparations of immediate cesarean section.


    b) Investigations:


     Blood investigations (Full blood count, blood group and type)


     Ultrasound examination: Rules out types of placenta previa; fetal anomalies, fetal parameters, presentation and position.


     Transabdominal ultrasonography (TAS):


     It should be with partially full bladder.


     It is a simple, precise, and safe method to visualize the placenta.


     TAS has an accuracy of 93-98%.


     Four types of placenta praevia according to abdominal sonography


    Type I- Dips in to lower segment


    Type II - Reaches lower border of uterus up to cervical os but not covering completely.


    Type III- covers the internal os


    Type IV - Covers the internal os, even on full dilatation of the cervix. At 18 weeks, 5-10% of placentas are low lying. Most ‘migrate’ with development of the lower uterine segment.


     False-positive results can occur secondary to focal uterine contractions or bladder distention.


     Transvaginal ultrasonography (TVS):


    Recent studies have shown that the transvaginal method is safer and more accurate than the transabdominal method. Transvaginal ultrasonography is also considered more accurate than transabdominal ultrasonography.


    – Skilled person should only do.


    – The os–placental edge distance on TVS after 35 weeks’ gestation is valuable in planning route of delivery. When the placental edge lies > 20 mm away from the internal cervical os, women can be offered a trial of labour with a high expectation of success. A distance of 20 to 0 mm away from the os is associated with a higher CS rate, although vaginal delivery is still possible depending on the clinical circumstances.


    – In general, any degree of overlap (> 0 mm) after 35 weeks is an indication for Caesarean section as the route of delivery


    c) Treatment :


     Assess the blood loss


     Resuscitate:


     Monitor BP


     Start IV Line


     Restore blood volume by infusing normal saline


     Explain the need of blood transfusion


     Arrangements made to shift to higher centres.


    d) Referral criteria:


    Shift to hospitals where blood bank, neonatal and emergency cesarean section facilities are available.


    Situation 2


    (At Super Specialty Facility in Metro location where higher-end technology is available)


    a) Clinical diagnosis: Diagnosis reached by history, physical examination and sonographic examination After initial assessment further investigations need to be performed to ascertain cause , degree of bleeding, plan the on-going care and to decide mode and time of delivery.


    b) Investigations: As above.


     Blood investigations (Full blood count, blood group and type)


     Ultrasound examination : Best investigative tool to diagnose placenta previa.


    Rule out all Four types of placenta previa:


    o Type I- Dips in to lower segment


    o Type II - Reaches lower border of uterus up to cervical os but not covering completely.


    o Type III- covers the internal os


    o Type IV - Covers the internal os, even on full dilatation of the cervix.


    – At 18 weeks, 5-10% of placentae are low lying. Most ‘migrate’ with 16 development of the lower uterine segment.


    - MRI: MRI has been suggested as a safe and alternate method and may be useful in determining the presences of placenta accreta/increta/percreta.


    c) Treatment:


     NO VAGINAL EXAMINATION


     Resuscitate:


     Monitor BP


     Assess the amount of bleeding.


     Start IV line


     Restore blood volume by blood products


    The definitive treatment depends upon the duration of pregnancy, fetal and maternal status and extent of hemorrhage:


     Type I and Type II anterior - vaginal delivery can be expected. Trial of vaginal delivery can be given and caesarean is done if patient bleeds


     Type II -b, III & IV - Elective/emergency caesarean section has to be done at the earliest.


    Guideline Source: Ministry of Health and Family Welfare


    http://clinicalestablishments.nic.in/WriteReadData/749.pdf
    Government of Indiaguideline on APHMinistry of Health and Family WelfarePlacenta PreviaTransabdominal ultrasonographyTransvaginal ultrasonography

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok